Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Eli Lilly ( LLY 0.36%) has been a great growth pick for investors over the past few years. The pharma company, thanks to its ...

We came across a bullish thesis on Eli Lilly and Company (LLY) on Business Model Mastery’s Substack. In this article, we will ...

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United States ...

Eli Lilly's potential Houston expansion could bring thousands of jobs and billions of dollars in investment to the area. Here's where the plant might be built ...

Eli Lilly is investing an additional $27 billion ... D.C., brings the company's total U.S. manufacturing investment to more than $50 billion since 2020. The company's previous total domestic ...

Eli Lilly will spend $3 billion expanding a ... Kenosha County earlier this year from Nexus Pharma as part of a massive manufacturing investment drive that aims to shore up supplies of drugs ...

Questions remain as to how FDA inspection differences between domestic and foreign drug facilities will play out.

Eli Lilly seems to have responded to the threat ... which it claims is the largest pharma manufacturing investment in US history. In a telling development, three of the four new sites will be ...

Eli Lilly is jockeying for a tax break in Texas ... but confirmed it’s related to the broader $27 billion U.S. manufacturing investment the company unveiled in late February.

Eli Lilly will spend more than $5 billion to ... Company officials said in a statement that this amounts to the largest manufacturing investment in the company's history, which dates back to ...

A major pharmaceutical manufacturing company is considering planting ground in Houston, with a $5.7 billion proposed investment into a new facility. Eli Lilly applied for a tax abatement under ...